0000886163-22-000012.txt : 20220128
0000886163-22-000012.hdr.sgml : 20220128
20220128204208
ACCESSION NUMBER: 0000886163-22-000012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220126
FILED AS OF DATE: 20220128
DATE AS OF CHANGE: 20220128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Berkman Charles S
CENTRAL INDEX KEY: 0001392266
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 22570916
MAIL ADDRESS:
STREET 1: 11085 NORTH TORREY PINES ROAD
STREET 2: SUITE 300
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-01-26
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001392266
Berkman Charles S
5980 HORTON STREET, SUITE 405
EMERYVILLE
CA
94608
0
1
0
0
SVP, Gen. Counsel & Secretary
Common Stock
2022-01-26
4
A
0
2401
0.0
A
30292
D
Common Stock
2022-01-26
4
A
0
3836
0.0
A
34128
D
Common Stock
2022-01-26
4
F
0
830
113.68
D
33298
D
Common Stock
2022-01-26
4
F
0
1326
113.68
D
31972
D
Represents the number of shares of common stock issued upon the vesting of performance stock units (PSUs). Each PSU represented a contingent right to receive one share of the Issuer common stock. The PSUs were originally granted on 05/29/2019 and were eligible to vest based on the Issuer achievement of certain performance objectives during the three-year performance period ending December 31, 2021. On January 26, 2022, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer achievement relative to the applicable performance objectives and approved the vesting of the PSUs with respect to these shares.
Represents the number of shares of common stock issued upon the vesting of performance stock units (PSUs). Each PSU represented a contingent right to receive one share of the Issuer common stock. The PSUs were originally granted on 03/09/2020 and were eligible to vest based on the Issuer achievement of certain performance objectives during the two-year performance period ending December 31, 2021. On January 26, 2022, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer achievement relative to the applicable performance objectives and approved the vesting of the PSUs with respect to these shares.
Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of the PSUs.
Charles S. Berkman
2022-01-28